Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

42.75p
   
  • Change Today:
      0.75p
  • 52 Week High: 48.40
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 2,754,763
  • Market Cap: £231.09m
  • RiskGrade: 119

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 (23.05) 4.28p 12.4 n/a -33% 1.78p 3.4%
31-Dec-23 180.68 (48.80) 4.55p 8.9 1.5 +6% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 189.35 39.58 4.43p 9.7 n/a -3% 1.36p 0.0%
31-Dec-25 202.27 41.39 5.06p 8.4 0.6 +14% 0.98p 0.0%
31-Dec-26 208.59 42.36 5.67p 7.5 0.6 +12% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 16.52 8.90 14.40 0.65

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 42.75p
Change Today 0.75p
% Change 1.79 %
52 Week High 48.40
52 Week Low 29.35
Volume 2,754,763
Shares Issued 540.57m
Market Cap £231.09m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.58% above the market average12.58% above the market average12.58% above the market average12.58% above the market average12.58% above the market average
91.84% above the sector average91.84% above the sector average91.84% above the sector average91.84% above the sector average91.84% above the sector average
Price Trend
22.33% below the market average22.33% below the market average22.33% below the market average22.33% below the market average22.33% below the market average
22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average
Income Not Available
Growth
41.79% below the market average41.79% below the market average41.79% below the market average41.79% below the market average41.79% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 11-Sep-2024

Time Volume / Share Price
17:06 599,486 @ 42.75p
16:35 5,829 @ 42.75p
16:35 16,799 @ 42.75p
16:35 109,149 @ 42.75p
16:35 1 @ 42.75p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page